Exploration of the underlying biological differences and targets in ovarian cancer patients with diverse immunotherapy response

Exploration of the underlying biological differences and targets in ovarian cancer patients with diverse immunotherapy response

BackgroundPreclinical trials of immunotherapy in ovarian cancer (OC) have shown promising results. This makes it meaningful to prospectively examine the biological mechanisms explaining the differences in response performances to immunotherapy among OC patients.MethodsOpen-accessed data was obtained...

Full description

Bibliographic Details
Main Authors: Jinjin Chen, Surong Chen, Xichao Dai, Liang Ma, Yu Chen, Weigang Bian, Yunhao Sun
Format: Article
Language:English
Published: Frontiers Media S.A. 2022-09-01
Series:Frontiers in Immunology
Subjects:
ovarian cancer
immunotherapy response
cancer-associated fibroblasts
machine learning
prognosis
Online Access:https://www.frontiersin.org/articles/10.3389/fimmu.2022.1007326/full

Internet

https://www.frontiersin.org/articles/10.3389/fimmu.2022.1007326/full

Similar Items